col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Georg Thieme Verlag KG: Thrombosis and Haemostasis
  original article Date Title Authors   All Authors
1 [GO] 2022―Jan―21 Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality György Sinkovits, Marienn Réti, Veronika Müller, Zsolt Iványi, János Gál, László Gopcsa, et al. (+16)
2 [GO] 2021―Nov―18 Heterogeneity of vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination and safety of second vaccination with BNT162b2 Edelgard Lindhoff-Last, Linda Schoenborn, Michael Piorkowski, Joerg Herold, Andreas Greinacher, Jo-Ann Sheppard, Theodore Warkentin
3 [GO] 2021―Nov―10 Comparison of thrombotic events and mortality in patients with community-acquired pneumonia and COVID-19: a multicentre observational study Roberto Cangemi, camilla calvieri, Marco Falcone, Francesco Cipollone, Giancarlo Ceccarelli, Pasquale Pignatelli, et al. (+16)
4 [GO] 2021―Nov―03 Activated Platelets Harbour SARS-CoV-2 During Severe COVID-19 Ejaife O. Agbani, Prism Schneider, Braedon McDonald, Leslie Skeith, Man-Chiu Poon, Adrienne Lee
5 [GO] 2021―Oct―13 Therapeutic vs. prophylactic bemiparin in hospitalized patients with non-severe COVID-19 (BEMICOP): an open-label, multicenter, randomized trial María Marcos, Francisco Carmona-Torre, Rosa Vidal Laso, PEDRO RUIZ-ARTACHO, David Filella, Cristina Carbonell, et al. (+9)
6 [GO] 2021―Sep―30 Acquired autoimmune Haemophilia following SARS-CoV-2 vaccines: Dual drug effects on blood coagulation and the Scylla and Charybdis phenomenon Job Harenberg, Marina Marchetti, Anna Falanga
7 [GO] 2021―Sep―06 Mild COVID-19 and Impaired Blood Cell-Endothelial Crosstalk: Considering Long-Term Use of Antithrombotics? Arthur Melkumyants, Ludmila Buryachkovskaya, Nikita Lomakin, Olga Antonova, Victor Serebruany
8 [GO] 2021―Aug―12 Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination Nadia Gabarin, Sarah Patterson, Menaka Pai, Tamoor Afzaal, Ishac Nazy, Jo-Ann Sheppard, et al. (+2)
9 [GO] 2021―Aug―05 Autoimmunity After Coronavirus Disease 2019 (COVID-19) Vaccine: A Case of Acquired Hemophilia A Scott Farley, Robert Ousley, Nicholas Van Wagoner, Fernando Bril
10 [GO] 2021―Aug―05 Modeling the effects of intravasal administration of AstraZeneca ChAdOx1 nCoV-19 vaccine on human platelets Pernille Just Vinholt, Henrik Frederiksen, Christian Nielsen
11 [GO] 2021―Jun―25 COVID-19 PANDEMIC UPDATES AND PERSPECTIVES. NEED FOR AN INTEGRATED AND EQUITABLE APPROACH. Grigoris Gerotziafas, Mariella Catalano, Ioannis Theodorou, Patrick van Dreden, Vincent Marechal, Alex Spyropoulos, et al. (+6)
12 [GO] 2021―Jun―15 ECMO induces early alterations in coagulation and fibrinolysis profiles in COVID-19 patients with acute respiratory distress syndrome. Guillaume Hékimian, Paul Masi, Manon Lejeune, Guillaume Lebreton, Juliette Chommeloux, Cyrielle Desnos, et al. (+9)
13 [GO] 2021―Jun―07 COVID-19 outbreak impact on anticoagulants utilization: an interrupted time-series analysis using healthcare administrative databases. Ippazio Cosimo Antonazzo, Carla Fornari, olga Paoletti, Claudia Bartolini, Sara Conti, Paolo Angelo Cortesi, et al. (+3)
14 [GO] 2021―Jun―03 Extracellular vesicles and citrullinated histone H 3 in coronavirus disease 2019 (COVID-19) patients Ludwig Traby, Marietta Kollars, Manuel Kussmann, Matthias Karer, Hana Sinkovec, Elisabeth Lobmeyr, et al. (+7)
15 [GO] 2021―May―07 COVID-19 and atrial fibrillation in older patients. Does oral anticoagulant therapy provide a survival benefit? An insight from the GeroCovid Registry Stefano Fumagalli, Caterina Trevisan, Susanna Del Signore, Giulia Pelagalli, Stefano Volpato, Pietro Gareri, et al. (+7)
16 [GO] 2021―May―04 SARS-CoV-2 vaccine and thrombosis: Expert opinions Ismail Elalamy, Grigoris Gerotziafas, Sonia ALAMOWITCH, Jean-Pierre LAROCHE, Patrick van Dreden, Walter Ageno, et al. (+6)
17 [GO] 2021―Apr―21 More on the source of D-dimer in COVID-19 Hau C Kwaan, Andrew P Mazar
18 [GO] 2021―Apr―17 Intermediate vs Standard-dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to ICU: Ninety-day Results from the INSPIRATION Trial Behnood Bikdeli, Azita H Talasaz, Farid Rashidi, Hooman Bakhshandeh, Farnaz Rafiee, Samira Matin, et al. (+54)
19 [GO] 2021―Apr―08 Platelet count rose while D-dimer levels dropped as deaths and thrombosis declined, an observational study on anticoagulation shift in COVID-19 Anna Sjöström, Johanna Wersäll, Anna Warnqvist, Maria Farm, Maria Magnusson, Anders Oldner, et al. (+3)
20 [GO] 2021―Apr―08 Anticoagulant treatment of COVID-19 as early as possible - Sulodexide and perspectives Sam Schulman, Job Harenberg
21 [GO] 2021―Apr―08 Significant major bleeding in hospitalized patients with COVID-19 receiving thromboprophylaxis Vicky Mai, Sabine Mainbourg, Boun Kim Tan, Jean-Christophe Lega, Steeve Provencher
22 [GO] 2021―Apr―06 Treatment-dose LMWH versus prophylactic/intermediate dose heparins in high risk COVID-19 inpatients: Rationale and design of the HEP-COVID Trial Mark Goldin, Dimitrios Giannis, Wassim Diab, Janice Wang, Sameer Khanijo, Gulru Sharifova, et al. (+19)
23 [GO] 2021―Mar―20 COVID-19 is associated with an acquired factor XIII deficiency. Fien von Meijenfeldt, Sebastian Havervall, Jelle Adelmeijer, Annika Lundstrom, Maria Magnusson, Nigel Mackman, et al. (+2)
24 [GO] 2021―Mar―07 Sulodexide in the treatment of patients with early stages of COVID-19: a randomized controlled trial Alejandro jose Gonzalez Ochoa, Joseph Raffetto, Ana Gabriela Hernandez Ibarra, Nestor Zavala, Obed Gutierrez, Arturo Vargas, Jorge Loustaunau
25 [GO] 2021―Feb―26 Severe SARS-CoV-2 infection inhibits fibrinolysis leading to changes in viscoelastic properties of blood clot: A descriptive study of fibrinolysis Stefanie Hammer, Helene Haeberle, Christian Schlensak, Michael Bitzer, Nisar Malek, Rupert Handgretinger, et al. (+10)
26 [GO] 2021―Feb―07 Assessment of Platelet Thrombus Formation under Flow Conditions in Adult Patients with COVID-19: An Observational Study Andrea Artoni, Mauro Panigada, Stefano Ghirardello, Anna Lecchi, Stefano Aliberti, Erica Scalambrino, et al. (+10)
27 [GO] 2021―Jan―21 Waves of SARS-CoV-2 Infection and Blood Coagulation-A Link and Beyond Job Harenberg, Francesco Violi
28 [GO] 2021―Jan―20 Prevalence and Predictors of Venous Thromboembolism or Mortality in Hospitalized COVID-19 Patients Stuart Lance Cohen, Eugenia Gianos, Matthew A Barish, Saurav Chatterjee, Nina Kohn, Martin Lesser, et al. (+6)
29 [GO] 2021―Jan―07 Platelets are hyperactivated but show reduced glycoprotein VI reactivity in COVID-19 patients. Valentine Léopold, Liza Pereverzeva, Alex R. Schuurman, Tom D.Y. Reijnders, Anno Saris, Justin de Brabander, et al. (+7)
30 [GO] 2021―Jan―07 Heparin in COVID-19 patients is associated with reduced in-hospital mortality: the multicentre Italian CORIST Study Augusto Filippo Di Castelnuovo, Simona Costanzo, Licia Iacoviello
31 [GO] 2021―Jan―05 Haemostasis in coronavirus disease 2019 - lesson from viscoelastic methods: a systematic review Artur Slomka, Mariusz Kowalewski, Ewa Żekanowska
32 [GO] 2020―Dec―31 Pharmacologic Thromboprophylaxis and Thrombosis in Hospitalized Patients with COVID-19: A Pooled Analysis Rushad Patell, Thita Chiasakul, Ethan Bauer, Jeffrey I. Zwicker
33 [GO] 2020―Dec―23 Albumin Supplementation Dampens Hypercoagulability in COVID-19: A Preliminary Report Francesco Violi, Giancarlo Ceccarelli, Lorenzo Loffredo, Francesco Alessandri, Francesco Cipollone, Damiano D'ardes, et al. (+5)
34 [GO] 2020―Dec―23 Hypercoagulopathy in Severe COVID-19: Implications for Acute Care Alicia A. C. Waite, David O. Hamilton, Roberto Pizzi, Walter Ageno, Ingeborg D. Welters
35 [GO] 2020―Dec―23 Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin Courtney J. Mycroft-West, Dunhao Su, Isabel Pagani, Timothy R. Rudd, Stefano Elli, Neha S. Gandhi, et al. (+19)
36 [GO] 2020―Dec―10 Contrast between Prevalence of HIT Antibodies and Confirmed HIT in Hospitalized COVID-19 Patients: A Prospective Study with Clinical Implications Maxime Delrue, Virginie Siguret, Marie Neuwirth, Caren Brumpt, Sebastian Voicu, Ruxandra Burlacu, et al. (+6)
37 [GO] 2020―Nov―20 Course of D-Dimer and C-Reactive Protein Levels in Survivors and Nonsurvivors with COVID-19 Pneumonia: A Retrospective Analysis of 577 Patients Luca Valerio, Paola Ferrazzi, Clara Sacco, Wolfram Ruf, Nils Kucher, Stavros V. Konstantinides, et al. (+2)
38 [GO] 2020―Nov―13 Anticoagulation in COVID-19: Effect of Enoxaparin, Heparin, and Apixaban on Mortality Henny H. Billett, Morayma Reyes-Gil, James Szymanski, Kenji Ikemura, Lindsay R. Stahl, Yungtai Lo, et al. (+6)
39 [GO] 2020―Oct―30 Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19 Selin Gencer, Michael Lacy, Dorothee Atzler, Emiel P. C. van der Vorst, Yvonne Döring, Christian Weber
40 [GO] 2020―Oct―30 Neutrophil-Platelet and Monocyte-Platelet Aggregates in COVID-19 Patients Alexandre Le Joncour, Lucie Biard, Mathieu Vautier, Helene Bugaut, Arsene Mekinian, Georgina Maalouf, et al. (+11)
41 [GO] 2020―Oct―24 Venous Thromboembolism in COVID-19 Sam Schulman, Yu Hu, Stavros Konstantinides
42 [GO] 2020―Sep―22 Derivation and Validation of a Predictive Score for Disease Worsening in Patients with COVID-19 Grigoris T. Gerotziafas, Theodoros N. Sergentanis, Guillaume Voiriot, Ludovic Lassel, Chryssa Papageorgiou, Alexandre Elabbadi, et al. (+11)
43 [GO] 2020―Sep―13 The Multiple Faces of Heparin: Opportunities in COVID-19 Infection and Beyond Ludovic Drouet, Job Harenberg, Giangiacomo Torri
44 [GO] 2020―Sep―13 Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine Grigoris T. Gerotziafas, Mariella Catalano, Mary-Paula Colgan, Zsolt Pecsvarady, Jean Claude Wautrecht, Bahare Fazeli, et al. (+68)
45 [GO] 2020―Sep―01 Mannose-Binding Lectin is Associated with Thrombosis and Coagulopathy in Critically Ill COVID-19 Patients Michael Hultström, Robert Frithiof, Oskar Eriksson, Barbro Persson, Miklos Lipcsey, Kristina Nilsson Ekdahl, Bo Nilsson
46 [GO] 2020―Aug―30 Staging Severity of COVID-19 according to Hemostatic Abnormalities (CAHA Score) Benjamin Marchandot, Antonin Trimaille, Anaïs Curtiaud, Adrien Carmona, Kensuke Matsushita, Chisato Sato, et al. (+7)
47 [GO] 2020―Aug―24 Coagulopathy and Thrombosis as a Result of Severe COVID-19 Infection: A Microvascular Focus Upendra K. Katneni, Aikaterini Alexaki, Ryan C. Hunt, Tal Schiller, Michael DiCuccio, Paul W. Buehler, et al. (+2)
48 [GO] 2020―Aug―22 Variability in Institutional Guidance for COVID-19-Associated Coagulopathy in the United States Rushad Patell, Shonali Midha, Stephen Kimani, Richard Martin, Natalia Neparidze, Michael Jaglal, et al. (+2)
49 [GO] 2020―Jul―29 A Liaison between Sudden Sensorineural Hearing Loss and SARS-CoV-2 Infection Job Harenberg, Jost B. Jonas, Eleonora M. C. Trecca
50 [GO] 2020―Jul―23 Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit Luca Spiezia, Annalisa Boscolo, Christelle Correale, Nicolò Sella, Elisa Pesenti, Luca Beghetto, et al. (+11)
51 [GO] 2020―Jul―17 Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis Shanen Jin, Yiyang Jin, Bai Xu, Jun Hong, Xianghong Yang
52 [GO] 2020―Jul―17 Obesity and COVID-19: A Virchow's Triad for the 21st Century Carl J. Vaughan, Heather Cronin, Paul MacDaragh Ryan, Noel M. Caplice
53 [GO] 2020―Jul―17 Personalizing Antithrombotic Therapy in COVID-19: Role of Thromboelastography and Thromboelastometry Rahul Chaudhary, Rolf P. Kreutz, Kevin P. Bliden, Udaya S. Tantry, Paul A. Gurbel
54 [GO] 2020―Jul―09 Fibrinolysis Resistance: A Potential Mechanism Underlying COVID-19 Coagulopathy Emmanuel Weiss, Olivier Roux, Jean-Denis Moyer, Catherine Paugam-Burtz, Larbi Boudaoud, Nadine Ajzenberg, et al. (+2)
55 [GO] 2020―Jun―23 Role of von Willebrand Factor and ADAMTS-13 in the Pathogenesis of Thrombi in SARS-CoV-2 Infection: Time to Rethink Nuccia Morici, Maurizio Bottiroli, Roberto Fumagalli, Claudia Marini, Marco Cattaneo
56 [GO] 2020―May―30 Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research Mahesh V. Madhavan, Behnood Bikdeli, Aakriti Gupta, David Jimenez, John R. Burton, Caroline Der Nigoghossian, et al. (+48)
57 [GO] 2020―May―26 Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy Betti Giusti, Anna Maria Gori, Manuel Alessi, Angela Rogolino, Elena Lotti, Daniela Poli, et al. (+9)
58 [GO] 2020―May―11 COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure Luca Spiezia, Annalisa Boscolo, Francesco Poletto, Lorenzo Cerruti, Ivo Tiberio, Elena Campello, et al. (+2)
59 [GO] 2020―May―06 Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines Zhenguo Zhai, Chenghong Li, Yaolong Chen, Grigorios Gerotziafas, Zhenlu Zhang, Jun Wan, et al. (+3)
60 [GO] 2020―Apr―29 Pulmonary Embolism or Pulmonary Thrombosis in COVID-19? Is the Recommendation to Use High-Dose Heparin for Thromboprophylaxis Justified? Marco Cattaneo, Elena M. Bertinato, Simone Birocchi, Carolina Brizio, Daniele Malavolta, Marco Manzoni, et al. (+2)
61 [GO] 2020―Apr―29 Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge Francesco Violi, Daniele Pastori, Roberto Cangemi, Pasquale Pignatelli, Lorenzo Loffredo
62 [GO] 2020―Apr―04 D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis Giuseppe Lippi, Emmanuel J. Favaloro


Last change 2022―Jan―20 20:43:25 UTC

© Daten-Quadrat 2022       Done in 0.010 sec